Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26189044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von David Mantle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharma Nord (UK) Ltd., Morpeth NE61 2DB, Northumberland, UK. Hauptthemen laut MEDLINE: Fatigue Syndrome, Chronic, Persian Gulf Syndrome, Fibromyalgia, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DOD CDMRP, Krupp Endowment Research Fund Award.
Abstract (Originalsprache)
Although Gulf War Illness (GWI), fibromyalgia (FM), myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID have distinct origins, in this article we have reviewed evidence that these disorders comprise a group of so-called low-energy associated disorders with overlapping common symptoms underlying pathology. In particular, evidence for mitochondrial dysfunction, oxidative stress, inflammation, immune dysregulation, neuroendocrine dysfunction, disrupted brain–gut-microbiome axis, apoptosis/ferroptosis and telomere shortening as common features in the pathogenesis of these disorders has been identified. Given the role of coenzyme Q10 (CoQ10) in promoting normal mitochondrial function, as an antioxidant, antiinflammatory and antiapoptotic and antiferroptotic agent, there is a rationale for supplementary CoQ10 in the management of these disorders. The reported benefits of supplementary CoQ10 administration in GWI, FM, ME/CFS and long COVID have been reviewed; the potential benefit of supplementary CoQ10 in reducing telomere shortening and improving the efficiency of stem cell transfer relevant has also been identified as promising therapeutic strategies in these disorders. This review advances beyond previous systematic reviews and consensus statements on overlapping similar symptoms and underlying biological pathomechanisms in these complex disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharma Nord (UK) Ltd., Morpeth NE61 2DB, Northumberland, UK.
- Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
- Department of Medicine, UC San Diego School of Medicine, La Jolla, CA 92093, USA.
- Research Unit in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID, Division of Rheumatology Research, Vall d'Hebron Hospital Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
ORCID-Profile: Joan Carles Domingo, Beatrice Alexandra Golomb, Jesús Castro-Marrero
Förderung
- DOD CDMRP
- Krupp Endowment Research Fund Award
Zitieren
APA
Mantle, D., Domingo, J. C., Golomb, B. A., & Castro-Marrero, J. (2025). Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189044
Vancouver
Mantle D, Domingo JC, Golomb BA, Castro-Marrero J. Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189044
BibTeX
@article{Mantle2025,
author = {Mantle, David and Domingo, Joan Carles and Golomb, Beatrice Alexandra and Castro-Marrero, Jesús},
title = {Gulf War Illness, Fibromyalgia, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Overlap in Common Symptoms and Underlying Biological Mechanisms: Implications for Future Therapeutic Strategies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26189044}
}
EUVIMED